About Highcroft

Investors who use what they back.

A venture capital firm built by physicians, for the advancement of medicine — combining rigorous investment discipline with the clinical judgment of those on the front lines of care.

Who We Are

Unparalleled insight, by design.

Highcroft Capital is a venture capital firm specializing in early-stage investments in medtech companies. Our team of physician investors has unparalleled industry insight and access to deal flow based on who we are.

We evaluate companies not just as investors, but as users of these technologies. Our mission is to transform the medical industry by supporting innovative and disruptive technologies with the potential to make the impossible possible.

The Highcroft edge

  • Proprietary deal flow sourced through clinical networks
  • Diligence informed by real-world clinical use
  • Physician credibility that founders seek out
  • Alignment of incentives across investors and portfolio

Investment Philosophy

Beyond financial returns.

Our investment philosophy extends beyond mere financial returns; we're driven by a commitment to advancing the standard of care in healthcare.

Leveraging our distinctive clinical perspective and broad network, we prioritize investing in transformational technologies with real-world clinical applications that have potential to reshape the industry landscape. Founders and fellow venture investors seek our involvement not only as a source of capital, but for the expertise and affiliations we bring to the table.

Our Approach

Three principles guide every investment.

01

Clinical First

We back technologies we would use ourselves — evaluating impact on patients and providers before projections.

02

Early & Active

We invest early and stay engaged, lending expertise, networks, and credibility well beyond capital.

03

Aligned Incentives

Disciplined structure keeps our interests aligned with our partners and our founders.

Meet the Partners

The physicians behind the firm.

Seasoned clinicians, entrepreneurs, and investors leveraging unique backgrounds to identify and support pioneering medtech ventures.

Meet the team